Premature Coronary Atherosclerosis in Scleroderma, a Case Control Study

This study is currently recruiting participants.

Verified by Tuen Mun Hospital, May 2008

Sponsored by:	Tuen Mun Hospital
Information provided by:	Tuen Mun Hospital
ClinicalTrials.gov Identifier:	NCT00372398

Purpose

To study the proportion of scleroderma patients who suffers from asymptomatic coronary atherosclerosis compared to healthy controls

Condition
Scleroderma

U.S. FDA Resources

Study Type:	Observational
Study Design:	Case Control, Cross-Sectional

Further study details as provided by Tuen Mun Hospital:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	40
Study Start Date:	October 2006
Estimated Study Completion Date:	February 2009
Estimated Primary Completion Date:	February 2009 (Final data collection date for primary outcome measure)

Detailed Description:

Coronary calcium scores will be obtained from a group of patients with scleroderma and a group of controls. Comparison of the calcium scores will be made.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Probability Sample

Study Population

scleroderma patients

Criteria

Inclusion Criteria:

Age >= 18 years.
Fulfillment of the American College of Rheumatology (ACR) criteria for the classification of scleroderma.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00372398

Contacts

Contact: CC Mok, MD, FRCP

ccmok2006@gmail.com

Locations

Hong Kong
Tuen Mun Hospital	Recruiting
Hong Kong, Hong Kong
Principal Investigator: Chi Chiu Mok, MD, FRCP

Sponsors and Collaborators

Tuen Mun Hospital

Investigators

Principal Investigator:

CC Mok, MD FRCP

Tuen Mun Hospital, Hong Kong

More Information

Responsible Party:	Tuen Mun Hospital, Hong Kong ( CC Mok )
Study ID Numbers:	NTWC/CREC/429/06
Study First Received:	September 5, 2006
Last Updated:	May 2, 2008
ClinicalTrials.gov Identifier:	NCT00372398
Health Authority:	Hong Kong: Ethics Committee

Keywords provided by Tuen Mun Hospital:

scleroderma, sclerosis, atherosclerosis

Study placed in the following topic categories:

Arterial Occlusive Diseases
Coronary Disease
Atherosclerosis
Heart Diseases
Myocardial Ischemia

Vascular Diseases
Sclerosis
Ischemia
Arteriosclerosis
Coronary Artery Disease

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 14, 2009